On Oct 6, 2020 JAMA published an article by R. Sachs (link below) that explains the impossible position different pieces of Federal legislation have created for State Medicaid programs. In this episode we break down the article and why it provides some insight into broader problems in prescription drug reimbursement. <a title="Confronting State Medicaid Drug Spending Pressures" href= "https://jamanetwork.com/journals/jama/fullarticle/2771844">source article</a> email: <a href= "mailto:econrxpodcast@gmail.com">econrxpodcast@gmail.com</a> Twitter/Instagram: @EconRx LinkedIn: <a href= "http://www.linkedin.com/company/econrx">www.linkedin.com/company/econrx</a> Website: <a href= "https://econrx.libsyn.com/">https://econrx.libsyn.com/</a>

Biosimilar Barriers

In this show we dive into the business of the US healthcare system. Why are some of my medications covered by insurance but not others? What does it mean for a provider to be "in-network?" Above all, WHERE DO OUR HEALTHCARE DOLLARS GO??! We want to understand and answer these questions, and we want you to come with us on this journey.